Newsroom
Category
October 1, 2024
Pancreatic ductal adenocarcinoma (PDAC), a certain type of pancreatic cancer, is a ruthless killer with an average five-year survival rate of less than 10%. Most patients are diagnosed at a late stage when the cancer has already spread throughout their bodies. And the problem is only growing worse. By 2030, pancreatic cancer is expected […]
September 30, 2024
Charles P. France, PhD, to lead methocinnamox drug development program The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was awarded a $12 million cooperative agreement (U01) from the National Institutes of Health’s National Institute on Drug Abuse to further develop methocinnamox (MCAM) as a treatment for opioid use disorder. […]
September 19, 2024
Content by Claire Kowalick The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received a collaborative $12.6 million program project grant from the National Cancer Institute to define the functions and regulation of BRCA1, BRCA2 and related tumor suppressor genes and find new ways to combat cancer. The $12.6 million grant […]
September 19, 2024
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was recently awarded a $12.6 million program project grant (P01) from the National Institutes of Health’s National Cancer Institute to expand collaborative efforts to explore the biological mechanisms of BRCA1, BRCA2 and related tumor suppressors and to shed light on potential […]
September 18, 2024
Weight-maintaining hormone key to brain-signal transmission New research is more closely linking obesity to dementia. Higher levels of leptin, a hormone that helps maintain normal body weight, is associated with better signal-transmitting brain white matter in middle-aged adults, according to a study by The University of Texas Health Science Center at San Antonio (UT Health […]
September 17, 2024
In landmark research, scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have reported the largest-ever genome-wide association study of dementia from all causes, revealing an overlap of genetic risks including neurodegeneration, vascular factors and cerebral small-vessel disease. Genome-wide association studies help scientists identify genes associated with […]
